Hong-Ji Xu

1.2k total citations
19 papers, 966 citations indexed

About

Hong-Ji Xu is a scholar working on Molecular Biology, Oncology and Ophthalmology. According to data from OpenAlex, Hong-Ji Xu has authored 19 papers receiving a total of 966 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 10 papers in Oncology and 7 papers in Ophthalmology. Recurrent topics in Hong-Ji Xu's work include Cancer-related Molecular Pathways (9 papers), Ocular Oncology and Treatments (7 papers) and Ubiquitin and proteasome pathways (5 papers). Hong-Ji Xu is often cited by papers focused on Cancer-related Molecular Pathways (9 papers), Ocular Oncology and Treatments (7 papers) and Ubiquitin and proteasome pathways (5 papers). Hong-Ji Xu collaborates with scholars based in United States, Spain and Japan. Hong-Ji Xu's co-authors include William F. Benedict, Gordon B. Mills, Robert C. Bast, Xianjun Fang, Ruth LaPushin, Rei Takahashi, Shuying Liu, Shuangxing Yu, Jiro ISHIKAWA and David W. Yandell and has published in prestigious journals such as Journal of Biological Chemistry, Oncogene and Biochemical and Biophysical Research Communications.

In The Last Decade

Hong-Ji Xu

19 papers receiving 936 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hong-Ji Xu United States	15	569	401	159	118	104	19	966
Jin-Yuh Shew Taiwan	12	533 0.9×	470 1.2×	222 1.4×	70 0.6×	58 0.6×	13	1.0k
Marilyn Skelly United States	11	385 0.7×	222 0.6×	122 0.8×	77 0.7×	32 0.3×	12	797
Kanji Hojo Japan	11	560 1.0×	242 0.6×	261 1.6×	90 0.8×	24 0.2×	21	974
Jana Karásková Canada	17	870 1.5×	379 0.9×	333 2.1×	68 0.6×	47 0.5×	22	1.4k
Virginie Caux‐Moncoutier France	11	653 1.1×	495 1.2×	234 1.5×	33 0.3×	16 0.2×	12	1.0k
W Zhang United States	13	550 1.0×	437 1.1×	259 1.6×	45 0.4×	58 0.6×	19	1.0k
Miki Hashimura Japan	23	731 1.3×	396 1.0×	255 1.6×	151 1.3×	12 0.1×	56	1.4k
Delphine S. Ally United States	4	634 1.1×	683 1.7×	301 1.9×	48 0.4×	52 0.5×	4	1.1k
Michael Tasch United States	6	950 1.7×	816 2.0×	157 1.0×	74 0.6×	33 0.3×	6	1.4k
Louise Aagaard Austria	6	921 1.6×	664 1.7×	133 0.8×	85 0.7×	59 0.6×	7	1.2k

Countries citing papers authored by Hong-Ji Xu

Since Specialization

Citations

This map shows the geographic impact of Hong-Ji Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hong-Ji Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hong-Ji Xu more than expected).

Fields of papers citing papers by Hong-Ji Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hong-Ji Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hong-Ji Xu. The network helps show where Hong-Ji Xu may publish in the future.

Co-authorship network of co-authors of Hong-Ji Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Hong-Ji Xu. A scholar is included among the top collaborators of Hong-Ji Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hong-Ji Xu. Hong-Ji Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Savaraj, Niramol, et al.. (2005). Redox regulation of matrix metalloproteinase gene family in small cell lung cancer cells. Free Radical Research. 39(4). 373–381. 25 indexed citations

Tacke, Frank, Frank C. Marini, Shourong Zhao, et al.. (2004). Expression of Inducible Bcl-XS in Myeloid Leukemia: Compensatory Upregulation of Bcl-XL and Bcl-2 Prevents Apoptosis and Chemosensitization. Cancer Biology & Therapy. 3(3). 340–347. 10 indexed citations

Fang, Xianjun, Shuangxing Yu, Robert C. Bast, et al.. (2004). Mechanisms for Lysophosphatidic Acid-induced Cytokine Production in Ovarian Cancer Cells. Journal of Biological Chemistry. 279(10). 9653–9661. 164 indexed citations

Liu, Shuying, Shuangxing Yu, Yutaka Hasegawa, et al.. (2004). Glycogen Synthase Kinase 3β Is a Negative Regulator of Growth Factor-induced Activation of the c-Jun N-terminal Kinase. Journal of Biological Chemistry. 279(49). 51075–51081. 40 indexed citations

Wu, Yun, Lu Dai, Feng Lin, et al.. (1999). Bcr: a negative regulator of the Bcr-Abl oncoprotein. Oncogene. 18(31). 4416–4424. 32 indexed citations

Koul, Dimpy, Ruth LaPushin, Hong-Ji Xu, et al.. (1998). p202 Prevents Apoptosis in Murine AKR-2B Fibroblasts. Biochemical and Biophysical Research Communications. 247(2). 379–382. 29 indexed citations

Fang, Xianjun, Xiaomei Jin, Hong-Ji Xu, et al.. (1998). Expression of p16 induces transcriptional downregulation of the RB gene. Oncogene. 16(1). 1–8. 72 indexed citations

Andreeff, M., Shi Xue Hu, Hong-Ji Xu, et al.. (1998). Low and maximally phosphorylated levels of the retinoblastoma protein confer poor prognosis in newly diagnosed acute myelogenous leukemia: a prospective study.. PubMed. 4(8). 1955–63. 15 indexed citations

Xu, Hong-Ji, Yunli Zhou, Russell Kruzelock, et al.. (1997). Reexpression of the retinoblastoma protein in tumor cells induces senescence and telomerase inhibition. Oncogene. 15(21). 2589–2596. 128 indexed citations

10.

Tamura, Kenji, Xue Zhang, Yoshinori Murakami, et al.. (1997). Deletion of three distinct regions on chromosome 13q in human non-small-cell lung cancer. International Journal of Cancer. 74(1). 45–49. 42 indexed citations

11.

Shi, Shan-Rong, Richard J. Côté, Christina J. Yang, et al.. (1996). DEVELOPMENT OF AN OPTIMAL PROTOCOL FOR ANTIGEN RETRIEVAL: A ‘TEST BATTERY’ APPROACH EXEMPLIFIED WITH REFERENCE TO THE STAINING OF RETINOBLASTOMA PROTEIN (pRB) IN FORMALIN-FIXED PARAFFIN SECTIONS. The Journal of Pathology. 179(3). 347–352. 61 indexed citations

12.

Xu, Hong-Ji, et al.. (1995). Retinoblastoma-like Phenotype Expressed in Medulloblastomas. Journal of Neuropathology & Experimental Neurology. 54(5). 664–672. 13 indexed citations

13.

Walther, McClellan M., James R. Gnarra, L J Elwood, et al.. (1995). Loss of Heterozygosity Occurs Centromeric to RB Without Associated Abnormalities in the Retinoblastoma Gene in Tumors from Patients with Metastatic Renal Cell Carcinoma. The Journal of Urology. 153(6). 2050–2054. 19 indexed citations

14.

Zhang, Wei, et al.. (1995). Growth-Factor Stimulation Reveals Two Mechanisms of Retinoblastoma Gene Inactivation in Human Myelogenous Leukemia Cells. Leukemia & lymphoma. 16(3-4). 191–198. 3 indexed citations

15.

Kubota, Yoshinobu, Hiroshi Miyamoto, Sumio Noguchi, et al.. (1995). The Loss of Retinoblastoma Gene in Association with c-myc and Transforming Growth Factor-beta 1 Gene Expression in Human Bladder Cancer. The Journal of Urology. 154(2). 371–374. 23 indexed citations

16.

Dodson, Mark K., William A. Cliby, Hong-Ji Xu, et al.. (1994). Evidence of functional RB protein in epithelial ovarian carcinomas despite loss of heterozygosity at the RB locus.. PubMed. 54(3). 610–3. 65 indexed citations

17.

Benedict, William F., Hong-Ji Xu, Shi Xue Hu, et al.. (1994). Loss of heterozygosity on chromosome 13 is common only in the biologically more aggressive subtypes of ovarian epithelial tumors and is associated with normal retinoblastoma gene expression.. PubMed. 54(3). 605–9. 67 indexed citations

18.

ISHIKAWA, Jiro, Hong-Ji Xu, Stella Hu, et al.. (1991). Inactivation of the retinoblastoma gene in human bladder and renal cell carcinomas.. PubMed. 51(20). 5736–43. 146 indexed citations

19.

Benedict, William F., Hong-Ji Xu, & Rei Takahashi. (1990). The Retinoblastoma Gene: Its Role in Human Malignancies. Cancer Investigation. 8(5). 535–540. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact